Predictive Biotech, Inc. Completes Development of Allograft Stem Cell Liquid Suspension Product

Company Introduces Its Latest Innovation in Regenerative Treatment Solutions SALT LAKE CITY, UT PRED, (Marketwired) Predictive Technology Group, Inc. (OTC PINK: PRED), announces that its wholly-owned subsidiary, Predictive Biotech, Inc. has finalized the development process of a new allograft stem cell product derived from umbilical cord blood(UCB). The use of UCB stem cells have gained popularity in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood and tissue The post Predictive Biotech, Inc. Completes Development of Allograft Stem Cell Liquid Suspension Product appeared first on Public Wire.
http://bit.ly/1Yzm69e

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: